$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Factors Related to N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for Heart Failure 원문보기

Journal of Korean biological nursing science, v.18 no.4, 2016년, pp.247 - 256  

Lee, Hyeong Suk (Seoul Women's College of Nursing) ,  Choi, Mona (College of Nursing, Yonsei University) ,  Oh, Eui Geum (College of Nursing, Yonsei University)

Abstract AI-Helper 아이콘AI-Helper

Purpose: This study aimed to examine the relationships between the N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels with the sociodemographic and clinical factors, self-care behaviors, and the physical symptom experiences in patients with heart failure. Methods: This cross-sectional stud...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

문제 정의

  • This cross-sectional study aimed to examine the relationships between the NT-proBNP levels and related factors of patients with heart failure. The study utilized a convenience sample of adult outpatients and inpatients who attended a cardiology department in a tertiary hospital in Seoul, Korea.
본문요약 정보가 도움이 되었나요?

참고문헌 (30)

  1. Fang JC, Ewald GA, Allen LA, Butler J, Westlake Canary CA, Colvin-Adams M, et al. Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee. Journal of Cardiac Failure. 2015; 21(6):519-534. http://dx.doi.org/10.1016/j.cardfail.2015.04.013 

  2. Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Journal of the American College of Cardiology. 2013;62(4):263-271. http://dx.doi.org/10.1016/j.jacc.2013.02.092 

  3. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6-e245. http://dx.doi.org/10.1161/CIR.0b013e31828124ad 

  4. Han SW, Ryu KH, Chae SC, Yang DH, Shin MS, Lee SH, et al. Multicenter analysis of clinical characteristics and prognostic factors of patients with congestive heart failure in Korea. Korean Circulation Journal. 2015;35(5):357-361. http://dx.doi.org/10.4070/kcj.2005.35.5.357 

  5. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. Journal of the American College of Cardiology. 2014;63(12):1123-1133. http://dx.doi.org/10.1016/j.jacc.2013.11.053 

  6. Allen F, Haroun R. Systematic review of the societal cost and economic burden associated with chronic heart failure. Value in Health. 2015;18(3):A139. http://dx.doi.org/10.1016/j.jval.2015.03.810 

  7. Gheorghiade M, Vaduganathan M. Rehospitalization for heart failure: problems and perspectives. Journal of the American College of Cardiology. 2013;61(4):391-403. http://dx.doi.org/10.1016/j.jacc.2012.09.038 

  8. Sethares KA, Chin E. Predictors of delay in heart failure patients and consequences for outcomes. Current Heart Failure Reports. 2015;12(1):94-105. http://dx.doi.org/10.1007/s11897-014-0241-5 

  9. Steinhubl S, Sun J, Vijayakrishnan R, Byrd R, Daar Z, Gotz D, et al. A3-2: The signs and symptoms of heart failure are frequently documented to wax and wane in the years prior to a clinical diagnosis of heart failure: data from 4,644 patients followed in primary care. Clinical Medicine & Research. 2013;11(3):134-135. http://dx.doi.org/10.3121/cmr.2013.1176.a3-2 

  10. Herr JK, Salyer J, Flattery M, Goodloe L, Lyon DE, Kabban CS, et al. Heart failure symptom clusters and functional status-a crosssectional study. Journal of Advanced Nursing. 2015;71(6):1274-1287. http://dx.doi.org/10.1111/jan.12596 

  11. Gluba A, Bielecka-Dabrowa A, Mikhailidis DP, Wong ND, Franklin SS, Rysz J, et al. An update on biomarkers of heart failure in hypertensive patients. Journal of Hypertension. 2012;30(9):1681-1689. http://dx.doi.org/10.1097/hjh.0b013e32835f668c 

  12. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2013;62(16):e147-e239. http://dx.doi.org/10.1016/j.jacc.2013.05.019 

  13. Stienen S, Salah K, Dickhoff C, Carubelli V, Metra M, Magrini L, et al. N-terminal pro-B-type natriuretic peptide (NT-proBNP) measurements until a 30% reduction is attained during acute decompensated heart failure admissions and comparison with discharge NT-proBNP levels: implications for in-hospital guidance of treatment. Journal of Cardiac Failure. 2015;21(11):930-934. http://dx.doi.org/10.1016/j.cardfail.2015.07.011 

  14. Galasko GI, Lahiri A. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? European Heart Journal. 2005;26(21):2269-2276. http://dx.doi.org/10.1093/eurheartj/ehi410 

  15. Bernstein LH, Zions MY, Haq SA, Zarich S, Rucinski J, Seamonds B, et al. Effect of renal function loss on NT-proBNP level variations. Clinical Biochemistry. 2009;42(10):1091-1098. http://doi.org/10.1016/j.clinbiochem.2009.02.027 

  16. Lee CS, Moser DK. Biomarkers of myocardial stress and systemic inflammation in patients who engage in heart failure self-care management. Journal of Cardiovascular Nursing. 2011;26(4):321-328. http://dx.doi.org/10.1097/jcn.0b013e31820344be 

  17. Peng CYJ, Lee KL. An introduction to logistic regression analysis and reporting. The Journal of Educational Research. 2002;96(1):3-14. http://dx.doi.org/ 10.4135/9781412983433.n4 

  18. Riegel B, Carlson B. Development and testing of a clinical tool measuring self-management of heart failure. Heart & Lung: The Journal of Acute and Critical Care. 2000;29(1):4-15. http://dx.doi.org/10.1016/s0147-9563(00)90033-5 

  19. Song EK, Kim CJ. Factors influencing functional status in patients with heart failure. Journal of Korean Academy of Nursing. 2006;36(5):853-862. 

  20. Son YJ, Kim SH. The influences of cognitive function on adherence to self care in elderly patients with heart failure. Korean Journal of Health Promotion. 2010;10(2):61-70. 

  21. Jaarsma T, Arestedt KF. The European Heart Failure Self-care Behaviour scale revised into a nine-item scale (EHFScB-9): a reliable and valid international instrument. European Journal of Heart Failure. 2009;11(1):99-105. http://dx.doi.org/10.1093/eurjhf/hfn007 

  22. Gaggin HK, Truong QA, Rehman SU, Mohammed AA, Bhardwaj A, Parks KA, et al. Characterization and prediction of natriuretic peptide "nonresponse" during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NTproBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study. Congestive Heart Failure. 2013;19(3):135-142. http://dx.doi.org/10.1111/chf.12016 

  23. Kato N, Kinugawa K, Ito N, Yao A, Watanabe M, Imai Y, et al. Adherence to self-care behavior and factors related to this behavior among patients with heart failure in Japan. Heart & Lung: The Journal of Acute and Critical Care. 2009;38(5):398-409. http://dx.doi.org/10.1016/j.hrtlng.2008.11.002 

  24. Zhang Y, Chen A. Association between baseline natriuretic peptides and atrial fibrillation recurrence after catheter ablation. International Heart Journal. 2016;57(2):183-189. http://dx.doi.org/10.1536/ihj.15-355 

  25. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. The Lancet. 2015;386(9989):154-162. http://dx.doi.org/10.1016/s0140-6736(14)61774-8 

  26. Gonell RLR, Arias-Mendoza A, Zarate JS, Pacheco HG, Sanchez CRM, Sangabriel AA, et al. Prognosis of acute decompensated heart failure in patients with preserved and reduced left ventricular ejection fraction based on N-terminal pro-B-type natriuretic peptide at admission. Journal of the American College of Cardiology. 2014;63(12):A794. http://dx.doi.org/10.1016/s0735-1097(14)60794-4 

  27. Ikonomidis I, Nikolaou M, Dimopoulou I, Paraskevaidis I, Lekakis J, Mavrou I, et al. Association of left ventricular diastolic dysfunction with elevated NT-pro-BNP in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue Doppler imaging parameters and NT-pro-BNP levels for adverse outcome. Shock. 2010;33(2):141-148. http://dx.doi.org/10.1097/shk.0b013e3181ad31f8 

  28. Mansoor A, Althoff K, Gange S, Anastos K, Dehovitz J, Minkoff H, et al. Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women. AIDS Research and Human Retroviruses. 2009;25(10):997-1004. http://dx.doi.org/10.1089/aid.2009.0038 

  29. Maries L, Manitiu I. Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP). Cardiovascular Journal of Africa. 2013;24(7):286-289. http://dx.doi.org/10.5830/cvja-2013-055 

  30. Sandersvan Wijk S, Muzzarelli S, Neuhaus M, Kiencke S, Maeder M, Estlinbaum W, et al. Safety and tolerability of intensified, Nterminal pro brain natriuretic peptideguided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIMELCHF. European Journal of Heart Failure. 2013;15(8):910-918. http://dx.doi.org/10.1093/eurjhf/hft079 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로